Chioato, A., Noseda, E., Stevens, M., Gaitatzis, N., Kleinschmidt, A., & Picaud, H. (2012). Treatment with the Interleukin-17A-Blocking Antibody Secukinumab Does Not Interfere with the Efficacy of Influenza and Meningococcal Vaccinations in Healthy Subjects: Results of an Open-Label, Parallel-Group, Randomized Single-Center Study. American Society for Microbiology.

Chioato, A., E. Noseda, M. Stevens, N. Gaitatzis, A. Kleinschmidt, et H. Picaud. Treatment With the Interleukin-17A-Blocking Antibody Secukinumab Does Not Interfere With the Efficacy of Influenza and Meningococcal Vaccinations in Healthy Subjects: Results of an Open-Label, Parallel-Group, Randomized Single-Center Study. American Society for Microbiology, 2012.

Chioato, A., et al. Treatment With the Interleukin-17A-Blocking Antibody Secukinumab Does Not Interfere With the Efficacy of Influenza and Meningococcal Vaccinations in Healthy Subjects: Results of an Open-Label, Parallel-Group, Randomized Single-Center Study. American Society for Microbiology, 2012.